While our study corroborates previous studies reporting low incidence of CT antigens in organ-confined prostate cancer, the increased MAGE-C2/CT10 antigen expression in advanced PCa was an unexpected novel finding. The gene discussed is MAGEC2; the disease is posterior cortical atrophy.